Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

AIM: To evaluate whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, could reduce the severity of gastric precancerous lesions following Helicobacter pylori (H pylori) eradication. METHODS: H pylori-eradicated patients with gastric precancerous lesions randomly received either celecox...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhang, Li-Jing, Wang, Shi-Yan, Huo, Xiao-Hui, Zhu, Zhen-Long, Chu, Jian-Kun, Ma, Jin-Cheng, Cui, Dong-Sheng, Gu, Ping, Zhao, Zeng-Ren, Wang, Ming-Wei, Yu, Jun
Natura: Artigo
Lingua:Inglês
Pubblicazione: The WJG Press and Baishideng 2009
Soggetti:
Orignal Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2695888/
https://ncbi.nlm.nih.gov/pubmed/19522023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.2731
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi